McDonald's Pilots Snack Wraps and Strips for 10% GLP-1 Drug Users
McDonald’s is piloting high-protein menu items—Snack Wraps, Sausage Biscuit sandwiches and McCrispy Strips—to cater to the estimated 10% of Americans using GLP-1 weight-loss drugs. Executives noted these customers prefer smaller portions and fewer sugary beverages, a shift that could alter average ticket composition and boost protein sales.
1. Menu Pilot Initiative
During a recent earnings call, McDonald’s CEO announced trials of high-protein offerings—Snack Wraps, Sausage Biscuit sandwiches and McCrispy Strips—designed to appeal to customers on GLP-1 medications. The pilot is ongoing across select U.S. markets to evaluate order volumes and customer feedback.
2. GLP-1 User Behavior
With roughly 10% of the U.S. population now using GLP-1 weight-loss drugs, McDonald’s observed shifts toward smaller portion sizes, reduced snacking and lower consumption of sugary drinks. Executives believe these behavioral changes will influence beverage mix and side and snack orders.
3. Potential Sales Impact
By targeting this growing customer segment, McDonald’s aims to adjust its average ticket mix toward higher-margin protein items. Long-term expansion plans for GLP-1 friendly offerings are in discussion but no firm rollout dates have been released.